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S St tu ud dy y D De es si ig gn n:: Mechanical study of polymethylmetacrylate (PMMA) mixed with blood as a filler.
P Pu ur rp po os se e:: An attempt was made to modify the properties of PMMA to make it more suitable for percutaneous vertebroplasty
(PVP).   
O Ov ve er rv vi ie ew w o of f L Li it te er ra at tu ur re e:: The expected mechanical changes by adding a filler into PMMA included decreasing the Young’ s
modulus, polymerization temperature and setting time. These changes in PMMA were considered to be more suitable and
adaptable conditions in PVP for an osteoporotic vertebral compression fracture.
M Me et th ho od ds s:: Porous PMMA were produced by mixing 2 ml (B2), 4 ml (B4) and 6 ml (B6) of blood as a filler with 20 g of reg-
ular PMMA. The mechanical properties were examined and compared with regular PMMA(R) in view of the Young’ s
modulus, polymerization temperature, setting time and optimal passing-time within an injectable viscosity (20-50 N-need-
ed) through a 2.8 mm-diameter cement-filler tube. The porosity was examined using microcomputed tomography.
R Re es su ul lt ts s:: The Young’ s modulus decreased from 919.5 MPa (R) to 701.0 MPa (B2), 693.5 Mpa (B4), and 545.6 MPa (B6). The
polymerization temperature decreased from 74.2℃ (R) to 59.8℃ (B2), 54.2℃ (B4) and 47.5℃ (B6). The setting time
decreased from 1,065 seconds (R) to 624 seconds (B2), 678 seconds (B4), and 606 seconds (B6), and the optimal passing-time
decreased from 75.6 seconds (R) to 46.6 seconds (B2), 65.0 seconds (B4), and 79.0 seconds (B6). The porosity increased from
4.2% (R) to 27.6% (B2), 27.5% (B4) and 29.5% (B6). A homogenous microstructure with very fine pores was observed in all
blood-mixed PMMAs.
C Co on nc cl lu us si io on ns s:: Blood is an excellent filler for PMMA. Group B6 showed more suitable mechanical properties, including a
lower elastic modulus due to the higher porosity, less heating and retarded optimal passing-time by the serum barrier,
which reduced the level of friction between PMMA and a cement-filler tube.
Key W Words :: Filler, Bone cement, Vertebroplasty, Osteoporotic verterbral compression fracture
Introduction
Vertebroplasty is a popular treatment for osteoporotic
vertebral compression fractures, and various preventive
strategies have been introduced to reduce the number and
severity of complications. Bone cement leakage and
embolism can occur when a lower viscosity cement is
infused through a cement filling tube with a relatively small
diameter
1,2. The cement that leaks into the spinal canal or
neural canal can cause stenosis, and a high polymerization
temperature can cause severe thermal injury to the nerve tis-sue
3,4. In addition, the vertebral body strengthened with the
cement itself might induce an adjacent vertebral compres-
sion fracture
5-7. To reduce these complications from verte-
broplasty, there have been several reports on the ideal
mechanical properties of the cement for vertebroplasty,
including methods for infusing the cement with high viscos-
ity and the use of cement with less strength and a lower
polymerization temperature
8-10. The porosity generated by
filler materials may allow the release of antibiotics loaded
in cement more easily but their Young’s modulus should be
decreased. On the other hand, the cement must be beneficial
in vertebroplasty and have other modified properties,
including a reduced setting time due to the faster polymer-
ization time and the lower polymerization temperature
10-12.
This study examined whether mixing blood into cement can
make the mechanical properties more suitable to vertebro-
plasty to reduce the number of complications.
Materials and Methods
1. Materials and mixing methods
Exolent Spine (Elmdown Ltd., London, UK) contained 20
g (20 ml) of polymer and 9.2 g (8 ml) of monomer per one
pack. The specimens were mixed in a operating room with a
room temperature of 18℃ and 21% humidity with the
cement preserved at room temperature for more than 24
hours. Six specimens were made in each group including
the regular cement group (R) and blood-mixed groups (B2,
B4, B6), which contained separately 2 ml, 4 ml, and 6 ml of
blood in a single pack of cement, respectively. One
researcher gave blood, which had a hemoglobin and hemat-
ocrit level of 16.7 mg/dl and 34.8%, respectively. It was
sampled immediately before being mixed with the cement
and should be mixed within a short time (about 1 minute
after sampling) prior to hematoma formation. Cement was
mixed evenly at a 2 Hz speed for approximately 45 seconds
and more 15 seconds after mixing the blood. The mixed
cement was transferred into a 20 ml regular syringe and
filled into a stainless mold with a 10 mm inner diameter and
a 30 mm height to make one block for the Young’s modu-
lus, and into three filler tubes with a 2.8 mm inner diameter
and 215 mm height to measure the optimal passing-time.
The cement remaining in the syringe was transferred into a
bowel to measure the polymerization temperature and set-
ting time. The cement block was easily separated by light
impact with a rod after 24 hours when the cement specimen
had hardened completely. The height and diameter was
manipulated accurately with sandpaper and inspected with
Venier Calipers (Mitutoyo, Kawasaki, Japan) with 0.05 mm
accuracy. The same procedures were repeated six times to
make six samples and collect the data in each group.
2. Study methods
The Young’s modulus was measured using an Instron
Micro-test system (Instron, Norwood, MA, USA) under a
compressive speed and load of 5 mm/minutes and 2 kN,
respectively. The Young’s modulus was defined as the
slope of the stress-strain curve. The displacement by load
was measured at 20 Hz and the data collected was analyzed
using Bluehill 2 software (Instron). The polymerization
temperature reached a maximum after mixing the polymer
and monomer, and was measured using an Infrared Ther-
mometer (AR852B; ARCO, Guangzhou, China) under the
condition of 0.9 emissivity and within 10 mm from the
specimen for the optimal optic-distance ratio. The setting
time was defined as the interval time from a mixing-start
point to a point reaching polymerization temperature
12. The
optimal passing time was defined as the possible interval
time for the cement with an optimal viscosity to pass
through a filler tube with a inner diameter of 2.8 mm using
a 20-50 N hand pushing pressure. The cement viscosity that
could be passed by less than 20 N hand pressure showed
more running fluid character, and the cement viscosity that
could be passed with 20-50 N showed sticky, tenacious and
malleable properties. The hardened cement that required
more than 60 N hand pressure could not be passed through
the cement filler tube and fixed to the pusher within the
tube. Considering these properties as cement hardened, the
optimal passing-time was determined to be the interval
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Fig. 1. Methods for measuring the pressure-related manipula-
tion time. A cement filler with a 2.8 mm diameter was connect-
ed to FGP-5. A jig can hold a cement filler tightly along the
parallel axis to FGP-5 to prevent unexpected resistant pressure
during cement-pushing. showing a certain viscosity equal to the 20-50 N hand pres-
sure. The pressure passing viscous fluid through a tube was
determined to be the viscosity coefficient and diameter of
the tube
8. A larger diameter tube has been already used for
higher viscosity cement in order to allow easy passing clini-
cally. Therefore, this study used a tube with a 2.8 mm inner
diameter and 215 mm length, which is generally used for
kyphoplasty. A zig was required to connect the filler tube
and a digital pressure gauge, FGP-5 (NIDEC-SHIMPO Cor-
poration, Kyoto, Japan) tightly and avoid unnecessary resis-
tant pressure evoked by a sagged axis. The minimal pres-
sure required to pass the cement through the tube was mea-
sured (Fig. 1). The porosity of the cement specimens was
measured using SkyScan 1076 Micro-CT System (Skyscan,
Aartselaar, Begium). The data was analyzed using the SPSS
15.0 (SPSS Inc., Chicago, IL, USA). The Young’s modulus,
polymerization temperature, setting time, optimal passing-
time and porosity were compared statistically using a one-
way ANOVA test to test the null hypothesis, and a Tukey’s-
b test with a Post Hoc multiple comparison test was used to
identify differences between the groups.
Results
The Young’s modulus of group R, B2, B4 and B6 was
919.5±148.2 MPa, 701.0±76.1 MPa, 693.5±104.1 MPa,
and 545.6±93.1 MPa, respectively. The Young’s moduli of
the Blood-mixed polymethylmetacrylate (PMMA) groups
were significantly lower than that of group R. The more
blood-mixed PMMA showed a lower modulus but the dif-
ference between the groups was not significant according to
the Post Hoc multiple comparison test (Table 1). The poly-
merization temperature of group R, B2, B4 and B6 was 74.2
±2.6℃, 59.8±2.2℃, 54.2±1.6℃, and 47.5±1.0℃,
respectively. The blood-mixed PMMA groups showed a
significantly lower polymerization temperature than that of
group R. In addition, the polymerization temperature and
setting time decreased with increasing amount of blood. 
The setting time of the group R, B2, B4 and B6 was 1065
±15 seconds, 624±8 seconds, 678±3 seconds, and 606±
8 seconds, respectively. The optimal passing-time of group
R, B2, B4 and B6 was 75.6±2.6 seconds, 46.6±2.3 sec-
onds, 65.0±6.1 seconds, and 79.0±4.2 seconds, respec-
tively. The optimal passing-time increased with increasing
amount of mixed blood but the setting time decreased. The
optimal passing-time of B2 was almost the same as that of
group R in the Post Hoc test.
The porosity of group R, B2, B4 and B6 in micro-CT was
found to be 4.2±0.6%, 27.6±1.7%, 27.5±1.4% and 29.5
±1.6%, respectively. The blood-mixed PMMA groups
showed similar porosity regardless of the amount of mixed
blood according to the Post Hoc test. Micro-CT revealed
micropores distributed evenly in the blood-mixed PMMA
groups (Fig. 2).
Discussion
Vertebroplasty with PMMA for osteoporotic vertebral
compression fracture is considered to be very successful in
that stabilization of fractured osteoporotic vertebral body
and dramatic pain relief. However, with the increasing use
of the procedure, many complications have been reported.
One of them was adjacent vertebral compression fractures,
which might be caused by outward factors including stress
transferred from a treated vertebra with PMMA, poor sagit-
tal balance and compensation of the upper body shifting
after pain relief, intradiscal cement leakage, cement config-
uration and an infused volume in the vertebral body as well
as an inward resistant factor, i.e. bone density
6,7,13-17. The
strength of PMMA was eight to forty times higher than that
of the osteoporotic vertebra. Therefore, harder PMMA in
the verterbral body could cause more stress transfer to the
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Table 1. Homogenous subsets by Tukey B test 
Tukey B test (Subset for alpha=0.05)
Group R B2 B4 B6
Young’s modulus 2 1 1 1
Polymerization temperature 4 3 2 1
Setting time 4 2 3 1
Manipulation time 3 1 2 3
Porosity 1 2 2 2surrounding cancellous bone, causing continuous refractur-
ing of a treated body or into the adjacent vertebral endplate,
resulting in an additional vertebral fracture
5,18. Lower modu-
lus PMMA or PMMA substitutes are recommended to
reduce the newly increasing stress transfer after vertebro-
plasty
19,20. The optimal modulus of PMMA for vertebroplas-
ty cannot be determined due to the combined mechanical
effects of the variety of causative factors on the adjacent
vertebral fractures. However, considering the strength of
PMMA only, a sufficient volume of PMMA supporting
both the upper and lower endplates in the vertebral body
was reported to increase the level of stress transfer by 670%
and 200% using 3,000 MPa and 100 MPa PMMA, respec-
tively
21. Therefore, the use of commercially available
PMMA with a modulus of 1,000 MPa for verterboplasty
can cause approximately 200-400% stress transfer. In addi-
tion, the modulus of osteoporotic vertebral body was con-
sidered in stress resistance. The elastic modulus of the
osteoporotic vertebral body was reported to be 34 MPa, 804
MPa, and 670 MPa in cancellous bone, cortical bone and
endplate, respectively
22, and the early recollapse rate was
reported to be 16% in vertebroplasty with lower modulus
substitutes, such as calcium phosphate cement
23. The opti-
mal modulus of PMMA was the modulus near the vertebral
body to prevent a treated veterbral body from refracture and
reduce the increase of stress transfer. The polymer to
monomer ratio was changed to reduce the modulus of
PMMA by 19.5% from 2,210 MPa to 1,780 MPa, but could
not reach the clinical requirements
11. Fifty percent mixing
with a radiopaque material could decrease the modulus by
95.7%, from 2,800 MPa to 120 MPa, but the result was also
ineffective clinically because PMMA with such a low mod-
ulus could not recover the strength of a treated vertebra to
the preinjured level
24. These results showed that 4 ml and 6
ml blood mixed PMMA showed a modulus of 701 MPa and
545.6 MPa, respectively, which is similar to the modulus of
cortical and endplate in an osteoporotic vertebral body. 
The moduli and porosities of the blood-mixed PMMAs
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Fig. 2. Micro-configuration on micro-CT. Blood-mixed polymethylmetacrylate’s (2B, 4B and 6B) showed homoge-
nous structures with fine regular pores.were unaffected by the volume of blood. The lack on an
increase in porosity with increasing blood volume was due
to the previous mixing of the polymer and monomer for 45
seconds, which might already produce a certain level of
polymerization, and the mixing methods with the hands in
which there could be a limitation of flourishing porosity
over a certain point. The early mixing of blood and PMMA
might allow considerable porosity to the blood-mixed
PMMA, but more porous PMMA was not required. Over-
plus blood, on the other hand, which did not be mixed with
PMMA, was shifted to the surface of PMMA and produced
a larger plasma barrier on the PMMA specimen.
Porosity caused by the mixing of a filler can reduce the
modulus of PMMA. A filler which is available in verterbro-
plasty to endow porosity, should have high viscosity, easy
resorption and release from PMMA, water solubility, bio-
compatibility and biodegradability
10. Boger et al.
10 reported
that when a pack of PMMA was mixed with sodium
hyaluronate at a 35% (13 ml) volume ratio, it resulted in a
56% porosity, a decrease in modulus and polymerization
temperature from 1,837 MPa to 477 MPa and from 68℃ to
41℃, respectively, which could prevent thermal injury to
the surrounding soft tissues. A very small amount of sodium
hyaluronate is already used in a bone substitute product.
However, such a large volume of sodium hyaluronate might
cause an embolism in the blood. Hence, the safety cannot be
guaranteed except for topical use in those regions from
which sodium hyaluronate could not be resorbed directly
into the blood
25.
A filler and additive mixed with PMMA can reduce the
polymerization temperature. A filler might produce pores in
PMMA, which can allow the polymerization heat to dissi-
pate quickly, and an additive may induce a new polymeriza-
tion reaction with a lower heat of reaction. One of the theo-
ries of pain relief by verterbroplasty was the thermal necro-
sis of the peripheral endings of the nerve fibers in the verte-
bral body. However, calcium phosphate cement with no
exothermic effect can show similar pain relief. On the other
hand, a microscopic study showed that micronecrosis
around PMMA after verterbroplasty was due to a resorption
process rather than to a foreign body reaction caused by
PMMA reaction heating or radiopaque barium
26,27. The cen-
tral temperature of PMMA in polymerization reached 49-
112℃, and the duration in which the temperature exceeded
50℃ lasted for almost 8 minutes, which might be enough to
injure the nerve tissue. If PMMA with the emission of sig-
nificant reaction heat leaked into the spinal canal, heat
transfer could be mostly intercepted by the continuous flow
of the cerebrospinal fluid (CSF), but the mass effect could
provoke stenosing neurologic symptoms. However, it would
cause thermal injury to the nerve tissue if it leaked into the
neural foramen and bordered on a root ganglion without the
flow of CSF. Therefore, the reaction heat in the polymeriza-
tion of PMMA should be lower
3,4,28,29. In the case of blood-
mixed PMMA, the polymerization temperature was as high
as 47.5-54.2℃, which is not believed to be enough to pre-
vent thermal injury but the temperature may be decreased
easily to a safe level on surrounding tissues in a shorter time
than that of regular PMMA.
According to the Hagen-Poiseuille law, the pressure
required in passing liquid PMMA through a filler tube is
dependent on the viscosity of the PMMA in direct propor-
tion
8.




�P: Pressure, μ : Fluid viscosity,  
L: Length of a tube, Q: Passing speed
π : pi, γ : Radius of a tube 
The setting time decreased in the blood-mixed PMMA,
which is similar to the same results of various filler-mixed
PMMAs. A decrease in setting times means that the viscosi-
ty is elevated faster and PMMA hardens earlier. Viscous
PMMA should be passed through a filler tube of a smaller
diameter during verterbroplasty rather than kyphoplasty. If
the viscosity is elevated over a certain level and an optimal
passing-point is missed, sufficient volume of PMMA could
not be infused into the verterbral body and become stuck in
the tube. However, the optimal passing-time of blood-
mixed PMMA was lengthened in proportion to the volume
of blood regardless of the shortened setting time, because of
the plasma barrier formed on the surface of the PMMA
specimen, which worked effectively as a lubricant between
the PMMA and the tube. The optimal passing-time of group
B6 was similar to that of group R but the setting time of
group B6 was reduced by 43% compared to group R.
Hence, the viscosity of group B6 was much higher than that
of group R at the same point of infusion, which can clinical-
ly reduce the risk of extravasation from a vertebral body or
an embolism of PMMA. 
Micro-CT revealed micropores which were distributed
evenly but not interconnected, so the PMMA and cancel-
lous bone could not be suspected to be conglutinated in the
processing of bone union. 
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be replaced for PMMA even in treatment for osteoporotic
vertebral compression fractures. Bone substitutes undergo a
process of crystallization without an exothermic effect in
the body temperature rather than polymerization. In addi-
tion, they can be resorbed by osteoclasts followed by the
remodeling of host bone, and do not release toxic sub-
stances like the monomer in PMMA
20,30,31. However, calcium
carbonate cement was resorbed very early within two to
four months after infusion, making unable to support a col-
lapsed body for sufficient time
32, and calcium phosphate
cement has a risk of recollapse of the fractured vertebral
body due to the very low strength
23,33. Calcium sulphate
cement can restore the treated vertebral strength to a similar
strength through regular PMMA but it has also a risk of
refracture of the treated verterbra due to the rapid
resorption
34,35. It is believed that the advantage of resorption
and replacement of calcium phosphate cement by the nor-
mal host bone does not exactly mean the recovery of bone
density and strength to those of the young and healthy ver-
tebra that would be sufficient to prevent refracture of an
osteoporotic vertebral body. In addition, the use of these
substitutes carries a risk of embolism, and the disintegration
tendency can deteriorate the pulmonary and arterial oxygen
tension in the aqueous environment of continuous blood
flow in a vertebral body in an experimental study
36. Hydrox-
yapatite is believed to overcome the disadvantages of regu-
lar PMMA and calcium phosphate cement. However, its
high viscosity can make handling and infusion more diffi-
cult and the resorption property can be obscure. Its use is
not yet prevalent because of its cost effectiveness
37,38. 
There were several limitations in this study due to the
aims of the study, which was focused on identifying the
clinical problems and solutions during performing vertebro-
plasty, and the measurement criteria and methods were
thought to be possibly affected by the subjective opinion by
researchers. The optic-distance ratio must be considered
when using an infrared thermometer as a noncontact mea-
surement. The recorded temperature would have been lower
than the real temperature if the temperature was measured
far from the acceptable distance according to optic-distance
ratio when the larger measured area was detected by a non-
contact measurement method. An infrared thermometer cal-
culates the average temperature over a certain area. The
emissivity of PMMA was believed to be 0.8-0.9, which is
similar to plaster or brick. Steinless showed lower emissivi-
ty. Therefore, the measured temperature would have been
much lower than the real polymerization temperature if the
polymerization temperature was measured on the surface of
a steinless mold containing PMMA. Accordingly, more
studies using similar instruments and objective methods
would be done to overcome these limitations and more
advisable and objective methods could be commented. 
Conclusions
Blood was used as a biocompatible filler to modify the
properties of bone cement to make it more suitable to verte-
broplasty by reducing the Young’s modulus to that of the
osteoporotic vertebral body and lowering the polymeriza-
tion temperature. The blood-mixed cement is believed to
have clinical benefits in vertebroplasty, in that a lower mod-
ulus can reduce the level of stress to the adjacent vertebrae.
In addition, the lubricant effect of the plasma membrane can
allow a high viscosity cement to pass smoothly under the
same pressure for passing regular cement to reduce a risk of
cement leakage and embolism. Furthermore, a lower poly-
merization temperature might also reduce a risk of thermal
injury to the nerve tissue.
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